Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Severe Behavioral Problems in Children with Intellectual Disability
NCT04821856Phase 2Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- May 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in behavioral disorder, sponsored by Murdoch Children's Research Institute. Started May 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
behavioral disorder
Beyond the preview
Go deeper on NCT04821856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821856.